Evista
| Evista | |
|---|---|
| Term | Evista |
| Short definition | Evidence-based medicine (EH-vih-dents-bayst MEH-dih-sin) A systematic medical approach in which physicians and other health professionals use the best available scientific evidence derived from clinical research use to make decisions about the treatment of individual patients. A physician's clinical experience and the patient's values and preferences are also important to the process of using evidence to make decisions. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Evista - (pronounced) (ee-VIS-tuh) A drug used to reduce the risk of invasive breast cancer in postmenopausal women who are at high risk of developing this disease or who have osteoporosis, and for Prevention and treatment of osteoporosis in postmenopausal women. Evista is also being studied to treat other types of cancer. It blocks the effects of the hormone estrogen in breast tissue, which can help prevent breast cancer cells from growing. Evista can also help prevent bone loss. It is a type of Selective Estrogen Receptor Modulator (SERM). Also called raloxifene hydrochloride
External links
- Medical encyclopedia article on Evista
- Wikipedia's article - Evista
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski